Results summary | View all lists in L2L MDB | View all genes in L01X.profile.u50 |
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 3.71-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
211745_X_AT | HBA1 | ![]() |
![]() |
hemoglobin, alpha 1 | |||||||||
215501_S_AT | DUSP10 | X | P | S | ![]() |
![]() |
dual specificity phosphatase 10 | ||||||
207419_S_AT | RAC2 | S | ![]() |
![]() |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | ||||||||
208892_S_AT | DUSP6 | P | S | ![]() |
![]() |
dual specificity phosphatase 6 | |||||||
212423_AT | C10ORF56 | ![]() |
![]() |
||||||||||
38037_AT | HBEGF | G | D | X | S | ![]() |
![]() |
heparin-binding EGF-like growth factor |